跳至主要内容
临床试验/CTRI/2020/01/022718
CTRI/2020/01/022718已完成2 期

An open label clinical trial to evaluate the efficacy of Rovaan Poshak Taila in the management of Khalitya (Diffuse Alopecia)

Multani Pharmaceuticals Ltd0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Subjects having diffuse hair fall
  • Subjects willing to participate in the study
  • Subjects able to provide signed ICF prior to any study related procedure

排除标准

  • 1.Subjects below 18 years and above 45 years of age
  • 2.Subjects on immunosuppressive drugs with evidence of skin infection
  • 3.Subjects who had used any topical therapy for diffuse hair loss in the 2 weeks prior to the initiation of study
  • 4.Individuals with immediate life threatening diseases such as pre-existing cardiovascular, liver or neoplastic diseases
  • 5.Individuals who received any immunosuppressant, sedative, hypnotic or tranquilizer within 14 days prior to enrollment
  • 6.Individuals with any psychiatric illness which may impair the ability to provide written ICF.
  • 7.Individuals participating in any other clinical trial.
  • 8.Pregnant and lactating females.

研究者

发起方
Multani Pharmaceuticals Ltd

相似试验

Management of Hair Fall through Rovaan Poshaka Taila | 临床试验